Semler Scientific (NASDAQ:SMLR) Stock Price Down 6.1% – Here’s Why

Semler Scientific, Inc. (NASDAQ:SMLRGet Free Report) fell 6.1% during mid-day trading on Tuesday . The stock traded as low as $54.74 and last traded at $55.36. 133,518 shares changed hands during trading, a decline of 63% from the average session volume of 359,435 shares. The stock had previously closed at $58.94.

Semler Scientific Price Performance

The stock has a market capitalization of $465.11 million, a P/E ratio of 24.48 and a beta of 1.18. The stock has a 50 day moving average price of $55.94 and a 200-day moving average price of $38.21.

Semler Scientific (NASDAQ:SMLRGet Free Report) last posted its quarterly earnings results on Monday, November 4th. The company reported $0.72 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.37 by $0.35. Semler Scientific had a return on equity of 20.31% and a net margin of 27.00%. The business had revenue of $13.51 million for the quarter.

Institutional Investors Weigh In On Semler Scientific

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Principal Financial Group Inc. purchased a new position in shares of Semler Scientific in the third quarter valued at about $361,000. Verition Fund Management LLC bought a new stake in shares of Semler Scientific in the third quarter worth about $251,000. Shariaportfolio Inc. purchased a new position in Semler Scientific during the 3rd quarter valued at about $3,618,000. Geode Capital Management LLC lifted its holdings in Semler Scientific by 10.5% in the 3rd quarter. Geode Capital Management LLC now owns 135,959 shares of the company’s stock worth $3,202,000 after buying an additional 12,964 shares during the period. Finally, Cerity Partners LLC lifted its holdings in Semler Scientific by 91.5% in the 3rd quarter. Cerity Partners LLC now owns 1,345,586 shares of the company’s stock worth $31,689,000 after buying an additional 642,982 shares during the period. 49.37% of the stock is currently owned by institutional investors.

About Semler Scientific

(Get Free Report)

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.

Further Reading

Receive News & Ratings for Semler Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Semler Scientific and related companies with MarketBeat.com's FREE daily email newsletter.